Bobkiewicz Adam, Studniarek Adam, Krokowicz Lukasz, Szmyt Krzysztof, Borejsza-Wysocki Maciej, Szmeja Jacek, Marciniak Ryszard, Drews Michal, Banasiewicz Tomasz
Department of General, Endocrinological Surgery and Gastroenterological Oncology, Poznan University of Medical Sciences, Przybyszewskiego 49, 60-355, Poznan, Poland.
Int J Colorectal Dis. 2017 Jan;32(1):107-111. doi: 10.1007/s00384-016-2661-z. Epub 2016 Sep 30.
Biofragmentable anastomosis ring (BAR) is an alternative to manual and stapled anastomoses performed within the upper and lower gastrointestinal (GI) tract. The aim of this study was to evaluate the effectiveness of BAR utility for bowel anastomoses based on our own material.
A retrospective analysis was performed to a total of 203 patients who underwent bowel surgery with the use of BAR anastomosis within upper and lower gastrointestinal tract between 2004 and 2014. Data for the analysis was collected based on medical records, treatment protocols, and the results of histological examinations.
The study group consisted of 86 women and 117 men. The most common underlying pathology was a malignant disease (n = 165). Biofragmentable anastomosis ring (BAR) size 31 was the most commonly used (n = 87). A total of 169 colocolic or colorectal anastomoses and 28 ileocolic and 8 enteroenteric anastomoses were performed. The mortality rate was 0.5 % (n = 1) whereas re-surgery rate within 30 days was 8.4 % (n = 17). Twenty-eight patients developed perioperative complications with surgical site infection as the most common one (n = 11). Eight patients developed specific complications associated with BAR including an anastomotic leak (n = 6) and intestinal obstruction (n = 2). The mean time of hospital stay after surgery was 12.7 days.
The use of BAR for the GI tract anastomoses is simple and rapid method and it is characterized with an acceptable number of perioperative mortality and complication rates. Based on our experience, we recommend the use of BAR anastomosis in different types of intestinal anastomosis in varying clinical scenarios.
生物可降解吻合环(BAR)是上、下消化道(GI)进行手工吻合和吻合器吻合之外的另一种选择。本研究的目的是基于我们自己的资料评估BAR在肠道吻合中的应用效果。
对2004年至2014年间在上、下消化道使用BAR吻合进行肠道手术的203例患者进行回顾性分析。分析数据基于病历、治疗方案和组织学检查结果收集。
研究组包括86名女性和117名男性。最常见的基础疾病是恶性疾病(n = 165)。31号生物可降解吻合环(BAR)是最常用的(n = 87)。共进行了169例结肠-结肠或结肠-直肠吻合、28例回肠-结肠吻合和8例肠-肠吻合。死亡率为0.5%(n = 1),而30天内再次手术率为8.4%(n = 17)。28例患者出现围手术期并发症,其中手术部位感染最为常见(n = 11)。8例患者出现与BAR相关的特殊并发症,包括吻合口漏(n = 6)和肠梗阻(n = 2)。术后平均住院时间为12.7天。
在胃肠道吻合中使用BAR是一种简单快捷的方法,其围手术期死亡率和并发症发生率在可接受范围内。基于我们的经验,我们建议在不同临床情况下的不同类型肠道吻合中使用BAR吻合。